In vivo administration of O(6)-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but does inhibit P450-dependent activation of dacarbazine

N J Toft, O J Sansom, R A Brookes, M J Arends, M Wood, G P Margison, D J Winton, A R Clarke

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'In vivo administration of O(6)-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but does inhibit P450-dependent activation of dacarbazine'. Together they form a unique fingerprint.

Medicine & Life Sciences